Category Archives: HealthCare

Latest Report on Global and China In-vitro Diagnostic Reagent Industry, 2013-2017 – Market Growth,Analysis And Forecast

MarketResearchReports.Biz announces addition of new report “Global and China In-vitro Diagnostic Reagent Industry, 2013-2017” to its database

 

In Chinese market, there are mainly three categories of invitro diagnostic reagents, biochemical diagnostic reagents, immune diagnostic reagents and molecular diagnostic reagents, accounting for about 65% of invitro diagnostic reagent market in total in 2012.
Global invitro diagnostics market is mature and the concentration rate is high. The 8 major enterprises account for over 70% market share. In 2011, the market scale of global invitro diagnostics reached USD 46 billion, among which developed countries accounted for over 80%. Currently, emerging economic entities occupy low proportions, while their growth rates are far ahead of that of mature markets.
To check out the Complete table of contents, visit: http://www.marketresearchreports.biz/analysis/172381
In China, barriers to entry of this industry are not high and the concentration rate is low. The majority of enterprises concentrate in the biochemical reagent field, so the competition is mainly in the biochemical field. Both the supply and demand of immune and molecular products are prosperous. In addition to immune reagents, markets of other diagnostic reagents are mainly occupied by Chinese domestic enterprises. Although China invitro diagnostic reagent industry started late and its scale is limited, it grows rapidly. In 2012, the market scale reached CNY 13.6 billion, among which immune diagnostic reagents, biochemical diagnostic reagents and molecular diagnostic reagents ranked among the top.
According to the investigation of CRI, the production line utilization of various invitro diagnostic reagent manufacturers is universally high. Therefore, CRI predicts that the production capacity of the industry will expand in the future. Furthermore, the development strategy of most enterprises is transversely enriching product varieties and vertically developing towards the upstream and downstream.

Contact US

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/

Global and China Human Vaccine Industry 2013-2017 – Worldwide Industry Trends,Size,Share

MarketResearchReports.Biz announces addition of new report “Global and China Human Vaccine Industry, 2013-2017” to its database

The research object of the report is human vaccines. According to different types and sources, vaccines can be divided into pathogenic protein vaccine, recombinant protein vaccines, immune protein vaccines and gene vaccines.
In China, vaccines are generally divided into Vaccine I and Vaccine II. Vaccine I is offered for free, and it’s priced and purchased uniformly by the government, covering the major epidemic diseases of Hepatitis B, epidemic cerebrospinal meningitis, Tetanus, etc. Vaccine II is other vaccines inoculated voluntarily at residents’ own expense. It is independently priced and has large profit margins, but there are intense competition in the market. The frequentlyused Vaccine II includes Pneumonia vaccine, Varicella Vaccine, Type B Haemophilus Influenzae Conjugate Vaccine, Influenza Vaccine, Rabies Vaccine and so on. In China, Vaccine I market are occupied by stateowned enterprises, while foreignfunded enterprises and private enterprises have certain advantages in Vaccine II market.
To check out the Complete table of contents, visit: http://www.marketresearchreports.biz/analysis/172380
In 2012, the scale of Chinese vaccine market was about CNY 19 billion, while the scale of pharmaceutical industry was about CNY 1.78 trillion in the same period. The sales revenue of Chinese vaccine industry was only about 1% of that of the pharmaceutical industry far below the global average level of 3%, estimated by CRI. There is still much space for growth. China has the largest population in the world with 10 million newborns yearly. Meanwhile, the aging of the society is increasingly serious. With the economic development and increasingly frequent population immigrations, it inevitably widens the spreading range and increases the speed of disease spreading. Accordingly, new epidemic diseases (Avian Influenza, Influenza A H1N1 and so on) occur frequently.

Data from China’s Ministry of Health shows, in 2012, China reported 3,216,900 cases of Class A and B infectious diseases, with16,721 dead. The reported incidence of Class A, B infectious diseases is 238.76/0.1million and the death rate is 1.24/0.1million. In 2012, China reported 3,734,500 cases of Class C infectious diseases, with 594 dead. The reported incidence of Class C infectious diseases is 277.18/0.1million and the death rate is 0.04/0.1 million. China’s infectious disease incidence reflects a growing trend comparing with that in previous years, which gradually prompts government’s attention on prevention and control of infectious diseases and planned immunization coverage is expanding; public awareness of vaccination is also increasing continuously which promotes the growth of vaccine market.

 

Contact US

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/

2013 Market Report on Global Epigenetic and MicroRNA Biomarkers Market – Worldwide Industry Share,Size,Trends

MarketResearchReports.Biz announces addition of new report “Epigenetic and MicroRNA Biomarkers 2013 Market Report” to its database

This market report from SELECTBIO represents the most up-to-date analysis of the Epigenetic and MicroRNA Biomarkers spaces together with research market data [qualitative and quantitative analysis] characterizing the epigenetics and microRNA research fields.

To check out the Complete table of contents, visit: http://www.marketresearchreports.biz/analysis-details/epigenetic-and-microrna-biomarkers-2013-market-report

The epigenetic and microRNA biomarkers fields are co-evolving and have reached a critical point wherein enough signatures have been identified across various different disease classes, most notably in cancer, that some of these signatures/expression patterns can be validated and deployed for use in the clinic.  However, these biomarker fields are evolving in parallel with the research marketplace, and therefore SELECTBIO has in this market report characterized the research markets for both these fields so as to present a comprehensive analysis that en bloc provides a complete picture of this expanding marketplace.

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/172004

Specific Topics Addressed in this Market Report:

  • Epigenetics Research Market Analysis
  • Primary Market Survey to Characterize Research Market Trends based on Data Collected from Researchers
  • Breakout of Epigenetics Research Activity based on Epigenetic Modifications Studied
  • Segmentation of Epigenetics Research Activity based on Disease Classes Studied
  • Epigenetics Research Activity in Cancer–Quantitative Segmentation
  • Reagent Kits and Products in the Epigenetics Research Field [Details of Products from the Vendors in this Space are Presented and Analyzed]

Contact US

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/

Blog: http://mrrbiz.blogspot.com/

Just Release: China Poultry Vaccine Market Analysis Report : MarketResearchReports.Biz

MarketResearchReports.Biz announces addition of new report “China Poultry Vaccine Market Analysis” to its database

China poultry vaccine market analysis is an invaluable asset for anyone who wants to invest in the poultry vaccine industry, to import into/from China, to build factories in China, to partner with one of the key Chinese corporations, or to compete in the segment.

The report provides in-depth analysis and detailed insight into the poultry vaccine industry, market drivers, key enterprises and their strategies, related policies, laws and standards for the industry, price trends, import and export data, projects to be constructed in China, forecasts, as well as technologies and investment status, risks and trends.

To check out the Complete table of contents, visit: http://www.marketresearchreports.biz/analysis-details/china-poultry-vaccine-market-analysis

The poultry vaccine indicates the products reproduced and processed from the pathogenic micro-organisms with good immunogenicity and can immunize vaccinated poultry and prevent poultry diseases.

At present, there are many types of livestock and poultry vaccines with advanced technologies and wide application, which can be used to control infectious livestock and poultry diseases quite efficiently and safeguard development of the livestock breeding and poultry raising industry.

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/171978

China’s animal vaccine market can be divided into two types, mandatory vaccines for government procurement and vaccines for market sales. There are only 5 types of mandatory vaccines and more are market vaccines. However, mandatory vaccines in China still accounts for over 50% of the market share. Its market competition is fierce, but the room for growth is limited. However, no matter in terms of new product development or improvement of animal protection rate, the market vaccine has ampler room for development. Organized viral vaccines take a large share in the poultry vaccines.

Data sources: National statistics organizations, market research (monitoring) center, industry associations (institutes), import/export statistics organizations.

 

 

Contact US

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/

Blog: http://mrrbiz.blogspot.com/